-
High R&D investment: As an industry driven by innovation, the development of new drugs is a lengthy process with high costs and a significant risk of failure.
-
Strong policy supervision: From research and development, clinical trials, production to sales and distribution, all are subject to strict supervision by the national drug regulatory authorities (such as GMP).
-
Quality requirements are extremely strict: There are nearly unrelenting demands for product purity, stability and consistency. Quality is the lifeline.
-
High profits with high risks: Patented drugs enjoy a period of market exclusivity and high profits, but after the patent cliff, profits will plummet sharply.
-
High market entry barriers: New products need to go through complex approval and bidding processes before they can enter the market.
-
The demand is relatively rigid: The product is related to people's health, and the market demand is less affected by macroeconomic fluctuations and has a relatively low elasticity.
Pharmaceutical manufacturing industry

Industry characteristics
Digital transformation goals
Solution
With the "Small, Fast, Lightweight and Precise" management series, we provide small and medium-sized manufacturing enterprises with lightweight, simple, efficient and precisely adapted production operation management solutions.
Typical case